Seeger Weiss Whistleblower Case Against SpineFrontier Yields Another Criminal Guilty Plea

On May 12, 2026, former SpineFrontier, Inc. Chief Financial Officer Aditya Humad pleaded guilty to one count of conspiracy to violate the federal Anti-Kickback Statute.

May 20, 2026

SpineFrontier Stephen Weiss

On May 12, 2026, former SpineFrontier, Inc. Chief Financial Officer Aditya Humad pleaded guilty to one count of conspiracy to violate the federal Anti-Kickback Statute, a charge stemming from a qui tam action in which Seeger Weiss founding partner Stephen A. Weiss and counsel Justin M. Smigelsky represent two of the relators.

Seeger Weiss has now been involved in five separate qui tam matters that resulted in criminal pleas or convictions, underscoring the firm’s sustained role in uncovering and pursuing significant fraud and misconduct through whistleblower litigation.

Humad admitted to paying more than $540,000 in bribes disguised as sham consulting fees to surgeons to induce them to use SpineFrontier’s spinal implant products in surgeries reimbursed by federal health care programs. Humad’s plea deal follows the May 2025 guilty pleas of SpineFrontier founder and CEO Dr. Kingsley R. Chin, surgeon Jason Montone, and medical device distributor John Balzer.

“The guilty plea this week by SpineFrontier, Inc.’s former CFO Aditya Humad is the latest development in a kickback scheme brought to light through a qui tam action filed by two relators represented by our firm, marking the fifth Seeger Weiss qui tam case to result in a criminal plea or conviction,” said Weiss. “Whistleblower cases like this one demonstrate that crime doesn’t pay, and that those whose fraud and corruption trigger False Claims Act violations risk severe consequences that far outweigh any gains when individuals with vigilance and courage come forward.”

Seeger Weiss is continuing to litigate this matter and its other active qui tam cases on behalf of whistleblower clients nationwide.

To learn more about Seeger Weiss’s whistleblower practice, visit seegerweiss.com/whistleblower-claims.

To learn more about the latest convictions, visit https://www.justice.gov/usao-ma/pr/cfo-boston-area-spinal-device-company-pleads-guilty-kickback-scheme.

Prior results do not guarantee or predict a similar outcome in any future matter.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More